Monacolin

Monacolin

Best for

Lower bad and total cholesterol

Proven strong benefit · 4–200 mg/day for 4–13 weeks · 1 meta-analysis , n=896

5 papers · 2 claims · 12 outcomes scored · 2 positive

Outcomes

What monacolin actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect Evidence Dose Weeks Rank
Lower bad and total cholesterol Proven strong benefit
large
5 meta-analyses n=896 Meta-analyzed 4–200 mg 4–13 wk #1/103
Raise good cholesterol levels Proven modest benefit
small
5 meta-analyses n=862 Meta-analyzed 5–200 mg 4–13 wk #3/71

Risk profile

Adverse events and known drug interactions

Safety events

headache mild
flatulence mild
muscle pain (myalgia) mild
muscle weakness mild
gastrointestinal upset / dyspepsia mild
myalgia
dizziness
reduced appetite

Want personalized recommendations?

Show me what works for me